AZD1480

For research use only.

Catalog No.S2162

87 publications

AZD1480 Chemical Structure

CAS No. 935666-88-9

AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM in a cell-free assay, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. Phase 1.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 130 In stock
USD 100 In stock
USD 170 In stock
USD 570 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's AZD1480 has been cited by 87 publications

Purity & Quality Control

Choose Selective JAK Inhibitors

Biological Activity

Description AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM in a cell-free assay, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. Phase 1.
Targets
JAK2 [1]
(Cell-free assay)
0.26 nM
In vitro

5μM AZD1480 induces G2/M arrest and cell death by inhibiting Aurora kinases. [1] AZD1480 is a potent JAK2 inhibitor that can suppress growth, survival, as well as FGFR3 and STAT3 signaling and downstream targets including Cyclin D2 in human multiple myeloma cells. At low micromolar concentrations, AZD1480 blocks cell proliferation and induces apoptosis of myeloma cell lines. [2]AZD1480 effectively blocks constitutive and stimulus-induced JAK1, JAK2, and STAT-3 phosphorylation in both human and murine glioma cells, and leads to a decrease in cell proliferation and induction of apoptosis. [3]AZD1480 is a potent, competitive small-molecule inhibitor of JAK1/2 kinase, and that it is capable of inhibiting STAT3 phosphorylation and tumor growth in a STAT3-dependent manner. AZD1480 inhibits tumor angiogenesis and metastasis in part by affecting the tumor microenvironment. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
SW620 NH31TmFHfW6ldHnvckBCe3OjeR?= MWe1JO69VQ>? NH;x[nM1QCCq NUfxcXVbTE2VTx?= M3;u[4Jtd2OtczDKRWszN1OWQWSzJJNq\26jbHnu[y=> MoLDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV7NUS5O|QoRjJ3OUW0PVc1RC:jPh?=
LoVo  NXHXU297TnWwY4Tpc44hSXO|YYm= NYG4RZVDPSEQvF2= M4\QfVQ5KGh? MU\EUXNQ MVHicI9kc3NiSlHLNk9UXEGWMzDzbYdv[Wyrbne= MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTl3NEm3OEc,OjV7NUS5O|Q9N2F-
HN5 M3XCRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoDrO|IhcA>? MX\FR|UxRTNwOEGgxtEhOS57OTFOwG0> NHrtXmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUixNFAyOCd-MkW4NVAxOTB:L3G+
Cal33 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnvuO|IhcA>? MWXFR|UxRTNwM{egxtEhOC55NTFOwG0> NVTMPFhORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
UM-22B NUn2ZZdxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIG5eWc4OiCq MWLFR|UxRTJwNk[gxtEhOC5{NDFOwG0> MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
686LN M3nHPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUTYd3dHPzJiaB?= NFPuSGZGSzVyPUKuNFUhyrFiMT6zN{DPxE1? MoHlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
UM SCC-1 NXGxNVRlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4juWlczKGh? Ml7pSWM2OD1zLk[3JOKyKDBwNEKg{txO NVWwdYFFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
UM-22A NUDQW2RpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUW3NkBp MXHFR|UxRTFwM{KgxtEhOC5|OTFOwG0> MorvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
OSC19 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHrlRmU4OiCq M3T1bGVEPTB;MT6yOkDDuSByLkKwJO69VQ>? MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
PCI-52 NFjmPYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnXZO|IhcA>? M3jlNWVEPTB;MT6wNEDDuSByLkC5JO69VQ>? MlTXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
PCI-15B NETqO4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGP5W3A4OiCq MW\FR|UxRTBwOUmgxtEhOS55NDFOwG0> MlfpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
UMSCC-1 NIS4S2xHfW6ldHnvckBCe3OjeR?= Mn;lNE4xODB3LUGuOkDPxE1? NIXwTIMzPCCq M3L0[oFjem:pYYTld{BKVC144pETbY5lfWOnZDD1dE1z\We3bHH0bY9vKG:oIIDTWGFVO1S7ckewOeKhcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> MnTJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
Cal33 NYT0cGZOTnWwY4Tpc44hSXO|YYm= M3f2UVAvODByNT2zMlgh|ryP MYeyOEBp MXfhZpJw\2G2ZYOgTWwuPuLCk3nu[JVk\WRidYCtdoVofWyjdHnvckBw\iCyU2TBWFNVgXJ5MEZCpIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnXy MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
HH5 NWnmclh2TnWwY4Tpc44hSXO|YYm= M3rsVlAvODByNT2zMlgh|ryP Mn33NlQhcA>? M3Ty[oFjem:pYYTld{BKVC144pETbY5lfWOnZDD1dE1z\We3bHH0bY9vKG:oIIDTWGFVO1S7ckewOeKhcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
UM-22A NYTQbIczTnWwY4Tpc44hSXO|YYm= NGLDOlIxNjByMEWtNU43KM7:TR?= MkSzNlQhcA>? MVnhZpJw\2G2ZYOgTWwuPuLCk3nu[JVk\WRidYCtdoVofWyjdHnvckBw\iCyU2TBWFNVgXJ5MEZCpIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnXy MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
A1847 M2THbmZ2dmO2aX;uJGF{e2G7 MV:wMlA2NTFyIN88US=> M4TUTlI1KGh? MVXEUXNQyqB? NX3OWZFOemWmdXPld{BxcG:|cHjvdplt[XSnZDDTWGFVOyCuZY\lcJM> M2\6OFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
OVCAR-5 MVPGeY5kfGmxbjDBd5NigQ>? NF:5O2sxNjB3LUGwJO69VQ>? MmTpNlQhcA>? NEn4fGhFVVORwrC= NIfVRWRz\WS3Y3XzJJBpd3OyaH;yfYxifGWmIGPURXQ{KGyndnXsdy=> NILLRYc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[0OlAyPSd-MkW2OFYxOTV:L3G+
OVCAR-8 M4TDVGZ2dmO2aX;uJGF{e2G7 Ml63NE4xPS1zMDFOwG0> NVm4UFlbOjRiaB?= NXfwZ5BNTE2VT9Mg NULFPWVVemWmdXPld{BxcG:|cHjvdplt[XSnZDDTWGFVOyCuZY\lcJM> M4\YS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
MOVCAR-5447 M{iyNWZ2dmO2aX;uJGF{e2G7 NVXTW|F[OC5yNT2xNEDPxE1? MU[yOEBp MkD4SG1UV8Li NWDVOG1FemWmdXPld{BxcG:|cHjvdplt[XSnZDDTWGFVOyCuZY\lcJM> MlPmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4NE[wNVUoRjJ3NkS2NFE2RC:jPh?=
MOVCAR-5009 NEf5SGRHfW6ldHnvckBCe3OjeR?= MYKwMlA2NTFyIN88US=> NGP6N2YzPCCq MWjEUXNQyqB? NXXyRohyemWmdXPld{BxcG:|cHjvdplt[XSnZDDTWGFVOyCuZY\lcJM> NELHc5A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[0OlAyPSd-MkW2OFYxOTV:L3G+
A1847 NH\JU4VE\WyuIG\pZYJqdGm2eTDBd5NigQ>? MlPjNE4xPS1zMDFOwG0> M1fveVczKGh? MV3EUXNQ NWrwcoY1emWmdXPld{Bk\WyuII\pZYJqdGm2eTDheEB1cGViY3;uZ4VzdnS{YYTpc44hd2ZiNTFOwG0> Mlv5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4NE[wNVUoRjJ3NkS2NFE2RC:jPh?=
OVCAR-5 Mn7ER4VtdCCYaXHibYxqfHliQYPzZZk> NF\TbHIxNjB3LUGwJO69VQ>? NUX4TG0yPzJiaB?= NVfpNYViTE2VTx?= NXHSN|RremWmdXPld{Bk\WyuII\pZYJqdGm2eTDheEB1cGViY3;uZ4VzdnS{YYTpc44hd2ZiNTFOwG0> NGS5cGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[0OlAyPSd-MkW2OFYxOTV:L3G+
OVCAR-8  NYL6NZB4S2WubDDWbYFjcWyrdImgRZN{[Xl? MnTqNE4xPS1zMDFOwG0> M1rVV|czKGh? MVvEUXNQ MWry[YR2[2W|IHPlcIwhfmmjYnnsbZR6KGG2IITo[UBkd26lZYLueJJifGmxbjDv[kA2KM7:TR?= NEHhVYI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[0OlAyPSd-MkW2OFYxOTV:L3G+
OVCAR-5  NYTKbVVVSXCxcITvd4l{KEG|c3H5 NXmxZWZiOC53L{GvOUDPxE1? MVO0PEBp Ml[5SG1UVw>? NVf3[m9RcW6mdXPld{B{cWewaX\pZ4FvfCCjcH;weI9{cXNiYYSgbIlocCClb37j[ZJvfHKjdHnvci=> MlPwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4NE[wNVUoRjJ3NkS2NFE2RC:jPh?=
OVCAR-8  M1u4e2Fxd3C2b4Ppd{BCe3OjeR?= NHPkeIcxNjVxMT:1JO69VQ>? M3vCblQ5KGh? NV;rZYYzTE2VTx?= NX7mfVQ3cW6mdXPld{B{cWewaX\pZ4FvfCCjcH;weI9{cXNiYYSgbIlocCClb37j[ZJvfHKjdHnvci=> MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ2NkCxOUc,OjV4NE[wNVU9N2F-
AKRSL Mn61R4VtdCCYaXHibYxqfHliQYPzZZk> MUO3NkBp NVu5WWUyUUN3MP-8olExKM7:TR?= MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTVyNE[zOUc,OjV3MES2N|U9N2F-
PALJDL Ml:zR4VtdCCYaXHibYxqfHliQYPzZZk> NV\XOWJCPzJiaB?= MWTJR|UxRTJwNDFOwG0> NUftW2F[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW1NFQ3OzVpPkK1OVA1PjN3PD;hQi=>
MO4 NV3wbpdkTnWwY4Tpc44hSXO|YYm= MXywMlUwOS93IN88US=> MXe2JIg> MlrabY5pcWKrdIOgVE1UXEGWMzDlfJBz\XO|aX;uxsA> M2frR|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS5OVM2Lz5{NUG0PVU{PTxxYU6=
DU145  NVfrPJJCTnWwY4Tpc44hSXO|YYm= Mn3uNE0zODBibl2= NHLMfJkyKGkEoB?= NX:4OlNoe3WycILld5NmeyCLTD22MYFkfGm4YYTl[EBUfGG2MzDhcoQhTVKNMT:yJJNq\26jbHnu[y=> NXX6XWlxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS1O|c6PDJpPkK0OVc4QTR{PD;hQi=>
DU145  MYjGeY5kfGmxbjDBd5NigQ>? NWLZfFZWQDByIH7N NV3JXFRnPzJiaB?= NFq3VIZ{fXCycnXzd4V{KEmOLU[tbY5lfWOnZDDtbYdz[XSxcom= NYjhbZJYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS1O|c6PDJpPkK0OVc4QTR{PD;hQi=>
CWR22Rv1 M3rT[mZ2dmO2aX;uJGF{e2G7 Mk[wPFAxKG6P M4[zPFczKGh? NIXs[3h{fXCycnXzd4V{KEmOLU[tbY5lfWOnZDDtbYdz[XSxcom= NYn2TId5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS1O|c6PDJpPkK0OVc4QTR{PD;hQi=>
N592 MmrhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFrSTGdKSzVyPUCuPFQh|ryP MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
H82 NED0bXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2jjTmlEPTB;MT6zO{DPxE1? NF\3UG09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG1PFcxOSd-MkSxOVg4ODF:L3G+
GLC4 MonMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnmzTWM2OD1zLke5JO69VQ>? NIrDU|U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG1PFcxOSd-MkSxOVg4ODF:L3G+
H526 NGnkS5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGX3OWNKSzVyPUOuNFgh|ryP MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
H1173 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn3zTWM2OD1{LkO5JO69VQ>? NXH1dIdDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxOVg4ODFpPkK0NVU5PzBzPD;hQi=>
DMS114 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\u[FRKSzVyPUCuO|Mh|ryP M{m3VVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW4O|AyLz5{NEG1PFcxOTxxYU6=
NCI-N592 NUX6dZFtTnWwY4Tpc44hSXO|YYm= NVTLbVN6OC5|L{GvN{DPxE1? NY\jSo1VOjRiaB?= M1\2V4lv\HWlZYOgS|IwVSClZXzsJIN6[2ynIHHydoV{fA>? NFHVbY89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG1PFcxOSd-MkSxOVg4ODF:L3G+
GLC4 NHzURnRHfW6ldHnvckBCe3OjeR?= M4j1[FAvOy9zL{Og{txO NHLSe|kzPCCq NUPzRWlucW6mdXPld{BIOi:PIHPlcIwh[3mlbHWgZZJz\XO2 NIW3fmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG1PFcxOSd-MkSxOVg4ODF:L3G+
NCI-H82 MnPiSpVv[3Srb36gRZN{[Xl? NUnReZprOC5|L{GvN{DPxE1? M4frNVI1KGh? NWeyenlWcW6mdXPld{BIOi:PIHPlcIwh[3mlbHWgZZJz\XO2 MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
NCI-N592 NE\ReGxCeG:ydH;zbZMhSXO|YYm= NV3GepNPOC5|L{GvN{DPxE1? NYG3TYpmPDhiaB?= M4\BN4lv[3KnYYPld{B1cGVibHX2[Ywhd2ZiY3zlZZZm\C2FYYPwZZNmKDN? MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
GLC4 MnPYRZBweHSxc3nzJGF{e2G7 M{CwWlAvOy9zL{Og{txO MonKOFghcA>? MlrnbY5kemWjc3XzJJRp\SCuZY\lcEBw\iClbHXheoVlNUOjc4Dhd4UhOw>? M3vFNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW4O|AyLz5{NEG1PFcxOTxxYU6=
NCI-H82 MmjpRZBweHSxc3nzJGF{e2G7 M1LyS|AvOy9zL{Og{txO NXjLU3dGPDhiaB?= NEDz[mRqdmO{ZXHz[ZMhfGinIHzleoVtKG:oIHPs[YF3\WRvQ3HzdIF{\SB| NUiyUopCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxOVg4ODFpPkK0NVU5PzBzPD;hQi=>
CWR22Rv1  NXjORnpESXCxcITvd4l{KEG|c3H5 NYC5VYp4UUN3ME2wMlQ5OiEQvF2= NVfFPXZrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5OFIxQTVpPkKzPVQzODl3PD;hQi=>
CWR22Pc NW\sbIdFSXCxcITvd4l{KEG|c3H5 M{n6bWlEPTB;MD60N|gh|ryP M2C4PVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|OUSyNFk2Lz5{M{m0NlA6PTxxYU6=
PC-3 MXzBdI9xfG:|aYOgRZN{[Xl? M1XCcWlEPTB;MT63OVUh|ryP NVz1XWZoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5OFIxQTVpPkKzPVQzODl3PD;hQi=>
DU145 MmPRRZBweHSxc3nzJGF{e2G7 NWHEO2Y3UUN3ME2zMlUyPyEQvF2= MoTrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7NEKwPVUoRjJ|OUSyNFk2RC:jPh?=
RC165N NInQfmdCeG:ydH;zbZMhSXO|YYm= Ml33TWM2OD1{LkC4N{DPxE1? MnrIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7NEKwPVUoRjJ|OUSyNFk2RC:jPh?=
ARPE19 M1PucGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4n3[2ROW09? MoTITWM2OD1{ND6zPEDPxE1? MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
HEK293 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1frVGROW09? NGj1OFNKSzVyPUiuOlch|ryP M{[xO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
KCNR M{PEdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWPEUXNQ Mo\wTWM2OD1yLkS2JO69VQ>? MlPRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
SY5Y NUnRbYlXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml\WSG1UVw>? M4rTb2lEPTB;MD6zOkDPxE1? MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
BE2 NV;mSmFVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4jOSWROW09? M4j6emlEPTB;MD63NUDPxE1? M17telxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
AS M1;h[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXryTWtyTE2VTx?= NYfnZnY{UUN3ME2xMlU{KM7:TR?= MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
NGP NVXiN|l7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYfEUXNQ MojxTWM2OD1yLkW2JO69VQ>? MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
IMR32 NI\KWnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4C3dGROW09? MmrITWM2OD1yLk[2JO69VQ>? NFrpS4k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{WzNVkzOSd-MkO1N|E6OjF:L3G+
LAN5 M4PiPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTCUJlFVVOR MULJR|UxRTFwMESg{txO M2WxbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
RH18 MnSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjEUXNQ MUDJR|UxRTFwNEKg{txO NV\qfmFHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
RH30 M4jYW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnnISG1UVw>? M{KxOmlEPTB;MT6yOUDPxE1? MoT3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
RH17 NFH4bmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGT4bY1FVVOR Ml34TWM2OD1{LkWxJO69VQ>? NYPsZXVVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
RH28 NVrSN5F2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYjEUXNQ NYr2U|NYUUN3ME20MlI5KM7:TR?= M{LkW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
RH36 Mnj3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4HjXmROW09? NWjyPWJJUUN3ME21MlM4KM7:TR?= MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
RH41 MnGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLEUXNQ NU\kWmNzUUN3ME2wMlQ5KM7:TR?= NFOwU4g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{WzNVkzOSd-MkO1N|E6OjF:L3G+
RD MlyxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3HD[mROW09? MXzJR|UxRTRwM{Kg{txO MnfIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
TC32 NFzjSnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWXpUmt5TE2VTx?= MVHJR|UxRTNwOEWg{txO M4H0cVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
TC71 M13SXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{DPSGROW09? M3THbWlEPTB;ND6zN{DPxE1? MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
KCNR NX3qXnRrSXCxcITvd4l{KEG|c3H5 MWmwMlUwOS5yL{KuOUDPxE1? NUnjNHdXOjRiaB?= NIXLPWhFVVOR M4Lj[olv\HWlZYOgZY4hcW6lcnXhd4UhcW5iY3HzdIF{\SB|L{egZYN1cX[rdIm= MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
SY5Y M3HrRmFxd3C2b4Ppd{BCe3OjeR?= M2KxXFAvPS9zLkCvNk42KM7:TR?= NInhVmgzPCCq MknKSG1UVw>? NHnpN2dqdmS3Y3XzJIFvKGmwY4LlZZNmKGmwIHPhd5Bie2ViMz:3JIFkfGm4aYT5 M{nSU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
Rh18 M2DBfWFxd3C2b4Ppd{BCe3OjeR?= M{PxRVAvPS9zLkCvNk42KM7:TR?= MnHCNlQhcA>? NEO3dXJFVVOR NUHrUYozcW6mdXPld{BidiCrbnPy[YF{\SCrbjDjZZNx[XOnIEOvO{Bi[3Srdnn0fS=> MljuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
TC32 MmfjRZBweHSxc3nzJGF{e2G7 M3fyclAvPS9zLkCvNk42KM7:TR?= MViyOEBp M3Xqd2ROW09? MV;pcoR2[2W|IHHuJIlv[3KnYYPlJIlvKGOjc4Dhd4UhOy95IHHjeIl3cXS7 MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
KCNR MW\GeY5kfGmxbjDBd5NigQ>? MXKwMlUwOS5yL{KuOU82KM7:TR?= M1\LW|I1KGh? NUj3Z5FHTE2VTx?= NILWfoxqdmirYnn0d{Bjd3SqIHXu[I9o\W6xdYOgZ49ve3SrdIX0bZZmKGGwZDDJUE03NWmwZIXj[YQhW1SDVEOgZYN1cX[jdHnvci=> M{DHR|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
SY5Y MYHGeY5kfGmxbjDBd5NigQ>? NYLzVI9YOC53L{GuNE8zNjVxNTFOwG0> Moe2NlQhcA>? MkfBSG1UVw>? MV\pcohq[mm2czDic5RpKGWwZH;n[Y5wfXNiY3;ud5RqfHW2aY\lJIFv\CCLTD22MYlv\HWlZXSgV3RCXDNiYXP0bZZifGmxbh?= MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
Rh18 NGS1[HBHfW6ldHnvckBCe3OjeR?= M3yxZVAvPS9zLkCvNk42NzVizszN M{XFelI1KGh? NX\VOoJwTE2VTx?= Mn70bY5pcWKrdIOgZo91cCCnbnTv[4Vvd3W|IHPvcpN1cXS3dHn2[UBidmRiSVytOk1qdmS3Y3XkJHNVSVR|IHHjeIl3[XSrb36= M{jkUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
TC32 NGDXemVHfW6ldHnvckBCe3OjeR?= NGnQUIYxNjVxMT6wM|IvPS93IN88US=> M3rHbVI1KGh? NX7xPGMzTE2VTx?= NG\GcXdqdmirYnn0d{Bjd3SqIHXu[I9o\W6xdYOgZ49ve3SrdIX0bZZmKGGwZDDJUE03NWmwZIXj[YQhW1SDVEOgZYN1cX[jdHnvci=> M1TYV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
TPC-1 M1y1fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn:5NUDDvU1? NUHhXIpuOC12IHS= NVnKN2t4TE2VTx?= NIKyRVFqdmirYnn0d{Bk\WyuIHfyc5d1cCCjZoTldkAzKGRidILlZZRu\W62 M4fLN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEW2OFk6Lz5{M{C1OlQ6QTxxYU6=
MZ-CRC1  NXTtXlROT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVGxJOK2VQ>? Ml30NE02KGR? MUnEUXNQ NFvzcVNqdmirYnn0d{Bk\WyuIHfyc5d1cCCjZoTldkAyKGRidILlZZRu\W62 NGC2bY49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C1OlQ6QSd-MkOwOVY1QTl:L3G+
TT  MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGL1R|EyKML3TR?= MVGwMVQh\A>? M1nPW2ROW09? M{fPT4lvcGmkaYTzJINmdGxiZ4Lve5RpKGGodHXyJFEh\CC2cnXheI1mdnR? M3TtfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEW2OFk6Lz5{M{C1OlQ6QTxxYU6=
TPC-1 MkSxSpVv[3Srb36gRZN{[Xl? MVmxJOK2VQ>? NUPzcVA2PzJiaB?= M2jaWGROW09? M4fSOolv\HWlZYOgS|Eh[myxY3vh[4U> M1zCXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEW2OFk6Lz5{M{C1OlQ6QTxxYU6=
MZ-CRC1  MVjGeY5kfGmxbjDBd5NigQ>? NVjwN5ZPOSEEtV2= MWO3NkBp Mme1SG1UVw>? M2LrSYlv\HWlZYOgS|Eh[myxY3vh[4U> NWOxS29VRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwOVY1QTlpPkKzNFU3PDl7PD;hQi=>
TT  NXq0c3pxTnWwY4Tpc44hSXO|YYm= MXmxJOK2VQ>? MmL2O|IhcA>? NXPyUIViTE2VTx?= NIS4XI1qdmS3Y3XzJGcyKGKub3PrZYdm NF7VR3E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C1OlQ6QSd-MkOwOVY1QTl:L3G+
MZ-CRC1  MVTBdI9xfG:|aYOgRZN{[Xl? Mn\LNUDDvU1? NYDJXZd{PDhiaB?= MmCzSG1UVw>? MUTpcoR2[2W|IHHwc5B1d3Orcx?= NVf1dYN[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwOVY1QTlpPkKzNFU3PDl7PD;hQi=>
TT  MYDBdI9xfG:|aYOgRZN{[Xl? M4\EZVEhyrWP MYW0PEBp M3viZmROW09? M3fofYlv\HWlZYOgZZBweHSxc3nz NGjoTWo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C1OlQ6QSd-MkOwOVY1QTl:L3G+
HD-LM2 NXHwN|lIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGXtSnE4OuLCiXi= MVfEUXNQ NWLndXFUUUN3ME23Mlg1PCEQvF2= NUnsOolYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4NlkxQTRpPkKyPFI6ODl2PD;hQi=>
L-428 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml60O|LjiImq MUDEUXNQ NHrmb4ZKSzVyPUeuPVQ4KM7:TR?= MoDPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6MkmwPVQoRjJ{OEK5NFk1RC:jPh?=
KM-H2 NY\kcmVET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVz3NYtmPzMkgJno NV3UUnBQTE2VTx?= NGryZYxKSzVyPUGuN|A5KM7:TR?= NGLlU3A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyPVA6PCd-MkK4NlkxQTR:L3G+
L-540 Ml7XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NITGNI44OuLCiXi= NXfWUXBnTE2VTx?= M2LGRWlEPTB;OD6yNVYh|ryP NVTWdJFlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4NlkxQTRpPkKyPFI6ODl2PD;hQi=>
HD-LM2 MX\GeY5kfGmxbjDBd5NigQ>? MmCwNE4yNzBwNT:xM|Uh|ryP M{KzU|cz6oDLaB?= NE\J[GlFVVOR MmPybY5pcWKrdIOgV3RCXDNuIGPURXQ2KGGwZDDTWGFVPiCyaH;zdIhwenmuYYTpc44> NFS1eFI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyPVA6PCd-MkK4NlkxQTR:L3G+
L-428 NUnzSmxLTnWwY4Tpc44hSXO|YYm= NXiwSHoyOC5zL{CuOU8yNzVizszN M4mzWVcz6oDLaB?= MVzEUXNQ MmjYbY5pcWKrdIOgV3RCXDNuIGPURXQ2KGGwZDDTWGFVPiCyaH;zdIhwenmuYYTpc44> MknHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6MkmwPVQoRjJ{OEK5NFk1RC:jPh?=
KM-H2 MlTiSpVv[3Srb36gRZN{[Xl? NIPmc4YxNjFxMD61M|EwPSEQvF2= M32yUFcz6oDLaB?= MUXEUXNQ MUHpcohq[mm2czDTWGFVOyxiU2TBWFUh[W6mIGPURXQ3KHCqb4PwbI9zgWyjdHnvci=> NELJc4s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyPVA6PCd-MkK4NlkxQTR:L3G+
L-540 NEHz[ZNHfW6ldHnvckBCe3OjeR?= NVTrTmpzOC5zL{CuOU8yNzVizszN M1u1e|cz6oDLaB?= MWjEUXNQ M1X4cIlvcGmkaYTzJHNVSVR|LDDTWGFVPSCjbnSgV3RCXDZicHjvd5Bpd3K7bHH0bY9v NGfMXJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyPVA6PCd-MkK4NlkxQTR:L3G+
HD-LM2 M2Tse2Fxd3C2b4Ppd{BCe3OjeR?= NYPMWFVZOS93IN88US=> MmCyO|LjiImq NXizOJRITE2VTx?= MWXpcoR2[2W|IHHwc5B1d3Orcx?= MnraQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6MkmwPVQoRjJ{OEK5NFk1RC:jPh?=
L-428 MYrBdI9xfG:|aYOgRZN{[Xl? MnjHNU82KM7:TR?= Ml2xO|LjiImq M4rVeWROW09? M1fUeIlv\HWlZYOgZZBweHSxc3nz MlPzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6MkmwPVQoRjJ{OEK5NFk1RC:jPh?=
KM-H2 M3XLZWFxd3C2b4Ppd{BCe3OjeR?= MofUNU82KM7:TR?= MliwO|LjiImq MkjxSG1UVw>? MojtbY5lfWOnczDhdI9xfG:|aYO= MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{OUC5OEc,OjJ6MkmwPVQ9N2F-
L-540 MX\BdI9xfG:|aYOgRZN{[Xl? M1rsW|EwPSEQvF2= MX[3NwKBkWh? NHLFc3VFVVOR NWnwRVlMcW6mdXPld{BieG:ydH;zbZM> NVXlXYJCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4NlkxQTRpPkKyPFI6ODl2PD;hQi=>
U251-MG MkHESpVv[3Srb36gRZN{[Xl? NWPn[lJvOSEEtV2= NGHHNm0xNTF4IHi= NY\Je2tMcW6qaXLpeJMh[2:wc4TpeJV1cX[nIGPURXQuOyCjbnSgTmFMOiCjY4TpeoF1cW:w MlrTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyMke2PVEoRjJ{MEK3OlkyRC:jPh?=
U87-MG M{jNXWZ2dmO2aX;uJGF{e2G7 MoL5NUDDvU1? MXiwMVE3KGh? MWLpcohq[mm2czDjc45{fGm2dYTpeoUhW1SDVD2zJIFv\CCMQVuyJIFkfGm4YYTpc44> M{jPTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEK3OlkyLz5{MkCyO|Y6OTxxYU6=
4C8 NHvHN2tHfW6ldHnvckBCe3OjeR?= NX7BfIFFOSEEtV2= MYWwMVE3KGh? NHOyUIJqdmirYnn0d{Bkd26|dHn0eZRqfmViU2TBWE0{KGGwZDDKRWszKGGldHn2ZZRqd25? NF3xXHg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkCyO|Y6OSd-MkKwNlc3QTF:L3G+
U251-MG M4W4emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYmxM|ExKML3TR?= NVKxeHB6OjRxNEivO|IhcA>? NHfQfFlqdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44h[XRiYTDjc45k\W62cnH0bY9vKG:oIEGwJOK2VQ>? NUHQTZdrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwNlc3QTFpPkKyNFI4PjlzPD;hQi=>
U87-MG M3O1W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml;CNU8yOCEEtV2= MX:yOE81QC95MjDo MmjObY5pcWKrdIOgZ4VtdCCycn;sbYZmemG2aX;uJIF1KGFiY3;uZ4VvfHKjdHnvckBw\iBzMDFCuW0> NFfvWFU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkCyO|Y6OSd-MkKwNlc3QTF:L3G+
4C8 NHm2NYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWKxM|ExKML3TR?= NX\KUJIyOjRxNEivO|IhcA>? NEf1bo1qdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44h[XRiYTDjc45k\W62cnH0bY9vKG:oIEGwJOK2VQ>? MmS5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyMke2PVEoRjJ{MEK3OlkyRC:jPh?=
U266 NUfjTpB2SXCxcITvd4l{KEG|c3H5 MWiwMlUuOiEQvF2= NVqzNFZoPDhxN{KgbC=> MlnlbY5lfWOnczDhdI9xfG:|aYOg[I9{\SCmZYDlcoRmdnSueR?= NGnTS209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUG2OFUyPyd-MkGxOlQ2OTd:L3G+
Kms.11 MYjBdI9xfG:|aYOgRZN{[Xl? NYSzelJwOC53LUKg{txO NWTuXGR4PDhxN{KgbC=> NVfF[3lzcW6mdXPld{BieG:ydH;zbZMh\G:|ZTDk[ZBmdmSnboTsfS=> MmDNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzNkS1NVcoRjJzMU[0OVE4RC:jPh?=
8226 MljrRZBweHSxc3nzJGF{e2G7 NV3QO2pCOC53LUKg{txO NWi2SWFjPDhxN{KgbC=> MoTBbY5lfWOnczDhdI9xfG:|aYOg[I9{\SCmZYDlcoRmdnSueR?= NH;rSpU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUG2OFUyPyd-MkGxOlQ2OTd:L3G+
SET2 MWXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MnLGOFghcHK| NHLYR2RIem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBUTVR{IHPlcIx{KGW6cILld5NqdmdiSnHrNkBXPjF5RjDteZRidnRiYX\0[ZIhPDhiaILzJIJ6KE2WUzDhd5NigSxiR1m1NEA:KDBwMEG2JO69VS5? NIjwd3o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
SET2 NH7uXmVHfW6ldHnvckBie3OjeR?= NHfmTnkyKGi{ MX;Jcohq[mm2aX;uJI9nKFO2YYSzJJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDTSXQzKGOnbHzzJIFnfGW{IEGgbJIh[nliV3XzeIVzdiCkbH;0eIlv\yxiSVO1NEA:KDBwMEKzJO69VS5? MnvCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
SET2 NESxSnVHfW6ldHnvckBie3OjeR?= NYnrblAzOSCqch?= NF\yeYlKdmirYnn0bY9vKG:oIGP0ZZQ2KHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBUTVR{IHPlcIx{KGGodHXyJFEhcHJiYomgW4V{fGW{bjDicI91fGmwZzygTWM2OCB;IECuNFI2KM7:TT6= NIHkN3U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
HEL NXXCZlNOTnWwY4Tpc44h[XO|YYm= NVXPUm9DOSCqch?= MkixTY5pcWKrdHnvckBw\iCVdHH0OUBxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gTGVNKGOnbHzzJIFnfGW{IEGgbJIh[nliV3XzeIVzdiCkbH;0eIlv\yxiSVO1NEA:KDBwMESxJO69VS5? NY\xco56RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
Ba/F3 NELDUYtHfW6ldHnvckBie3OjeR?= Mn3nTY5pcWKrdHnvckBw\iCVdHH0OUBxcG:|cHjvdplt[XSrb36gbY4hdW:3c3WgRoEwTjNiY3XscJMh\XiycnXzd4lv\yCWRVytToFsOixiSVO1NEA:KDBwMES2JO69VS5? MoKxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
UKE1 MUHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? M3e3cVQ5KGi{cx?= Ml\2S5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gWWtGOSClZXzsd{BmgHC{ZYPzbY5oKEqja{KgWlYyP0ZibYX0ZY51KGGodHXyJFQ5KGi{czDifUBOXFNiYYPzZZktKEeLNUCgQUAxNjB3NDFOwG0v NEHT[4k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
BA/F3 M130ZWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NHfvOnY1QCCqcoO= NHvsSnhIem:5dHigbY5pcWKrdHnvckBw\iCvb4Xz[UBDSS:IMzDj[YxteyCneIDy[ZN{cW6pIGTlcE1LSUt{IHvpcoF{\SCjZoTldkA1QCCqcoOgZpkhVVSVIHHzd4F6NCCJSUWwJF0hOC5yNjFOwG0v MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
HEL MXjGeY5kfGmxbjDhd5NigQ>? MmjINUBpeg>? MUTJcohq[mm2aX;uJI9nKFO2YYSzJJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDISWwh[2WubIOgZYZ1\XJiMTDodkBjgSCZZYP0[ZJvKGKub4T0bY5oNCCLQ{WwJF0hOC5yODFOwG0v NUfiOWdLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
HEL Mn3sS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MX60PEBpenN? NV3LPYxUT3Kxd4ToJIlvcGmkaYTpc44hd2ZiaIXtZY4hUEWOIHPlcIx{KGW6cILld5NqdmdiSnHrNkBXPjF5RjDteZRidnRiYX\0[ZIhPDhiaILzJIJ6KE2WUzDhd5NigSxiR1m1NEA:KDBwM{mg{txONg>? MnLtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
BA/F3 M3XmRmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MUO0PEBpenN? MkizS5Jwf3SqIHnubIljcXSrb36gc4YhdW:3c3WgRmEwTjNiY3XscJMh\XiycnXzd4lv\yCWZXytTmFMOSCtaX7hd4Uh[W[2ZYKgOFghcHK|IHL5JG1VWyCjc4PhfUwhT0l3MDC9JFAvPyEQvF2u NILZXI09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
BA/F3 NVjJV5BGT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MVi0PEBpenN? MnLhS5Jwf3SqIHnubIljcXSrb36gc4YhdW:3c3WgRmEwTjNiY3XscJMh\XiycnXzd4lv\yCWZXytWJlsOiCtaX7hd4Uh[W[2ZYKgOFghcHK|IHL5JG1VWyCjc4PhfUwhT0l3MDC9JFIh|ryPLh?= MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
BA/F3 M2\HRWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MVi0PEBpenN? MUHHdo94fGhiaX7obYJqfGmxbjDv[kBud3W|ZTDCRU9HOyClZXzsd{BmgHC{ZYPzbY5oKFSnbD3KRWs{KGurbnHz[UBi\nSncjC0PEBpenNiYomgUXRUKGG|c3H5MEBIUTVyIE2gNk4yKM7:TT6= M323WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
UKE1 Mk[4SpVv[3Srb36gZZN{[Xl? MlzmNUBpeg>? NF;odo5KdmirYnn0bY9vKG:oIGP0ZZQ2KHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBWU0VzIHPlcIx{KGGodHXyJFEhcHJiYomgW4V{fGW{bjDicI91fGmwZx?= NWLQTI1WRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
SW620 NVHiVlg2S2WubDDjfYNt\SCjc4PhfS=> NUn5UZNsOy5|IIXN MlLpNlQhcHK| M2CwTWNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJHNYPjJyIHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMj;NJJBp[XOnIHH0JFMvOyC3TTDh[pRmeiB{NDDodpMh[nliZnzve{BkgXSxbXX0dpk> MmHUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
HEL MXfGeY5kfGmxbjDhd5NigQ>? M{\ybVAvOyC3TR?= NW\nb2ZjPSCvaX7z NGTNN4dKdmirYnn0bY9vKG:oIGP0ZZQ2KHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJTUxiY3XscJMh[XRiMD6zJJVOKGGodHXyJFUhdWmwczDifUBY\XO2ZYLuJIJtd3S2aX7n NHfNWG09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
HEL MnLJSpVv[3Srb36gZZN{[Xl? NWXoVm17OC5|IIXN Mo\2N|AhfG9iNkCgcYlvew>? MYTJcohq[mm2aX;uJI9nKFO2YYS1JJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDISWwh[2WubIOgZZQhOC5|IIXNJIFnfGW{IEOwJJRwKDZyIH3pcpMh[nliV3XzeIVzdiCkbH;0eIlv\w>? M1v1fVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
BA/F3 NXv4OnJlSW62aYT1cY9zKGG|c3H5 NVG1cm5NOzBibXevb4c> M3rHdFEzKGi{cx?= M2PiW2FvfGm2dX3vdkBi[3Srdnn0fUBi\2GrboP0JI1wfXOnIFLBM2Y{KGOnbHzzJIV5eHKnc4PpcochXGWuLVrBT|IhgGWwb3fyZYZ1\WRiaX6gUmNzKG2xdYPlJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDwbI9{eGixconsZZRm\CCVdHH0OUBt\X[nbDDpckB{eGynZX6gZZQhOzBibXevb4ctKHCxIHHmeIVzKDF{IHjyd{BjgSCZZYP0[ZJvKGKub4T0bY5o M3\iU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
HEL NVLBRVJkTnWwY4Tpc44h[XO|YYm= M4\1UFAvOyC3TR?= NUTkfmFNPSCvaX7z NYjERWRVUW6qaXLpeIlwdiCxZjDTeIF1OyCyaH;zdIhwenmuYYTpc44hcW5iaIXtZY4hUEWOIHPlcIx{KGG2IECuN{B2VSCjZoTldkA2KG2rboOgZpkhX2W|dHXyckBjdG:2dHnu[y=> MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
HEL NVjnT2IzTnWwY4Tpc44h[XO|YYm= MXWwMlMhfU1? NEDLbZk{OCC2bzC2NEBucW6| MXPJcohq[mm2aX;uJI9nKFO2YYSzJJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDISWwh[2WubIOgZZQhOC5|IIXNJIFnfGW{IEOwJJRwKDZyIH3pcpMh[nliV3XzeIVzdiCkbH;0eIlv\w>? NHH2dmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
Hs578T NUHuNFFNTnWwY4Tpc44h[XO|YYm= MV[xJJVO M{DCRVI1KGi{cx?= NWflO2QxUW6qaXLpeIlwdiCxZjDTWGFVO0NvbXXkbYF1\WRidILhcpNkemmydHnvckBqdiCqdX3hckBJezV5OGSgZ4VtdHNiYYSgNUB2VSCjZoTldkAzPCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7 Ml3sQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7N{ixNVIoRjJ2OUe4NVEzRC:jPh?=
NCI-H1975 NE\4WpJHfW6ldHnvckBie3OjeR?= MoTvNE4xODNidH:gN{B2VQ>? MnT4NkBpenN? NGe3OHpKdmirYnn0bY9vKG:oIFrBT|EhcW5iaIXtZY4hVkOLLVixPVc2KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDTWGFVOyCyaH;zdIhwenmuYYTpc44h[XRiMD6wNFMhfG9iMzD1UUBi\nSncjCyJIhzeyCkeTDX[ZN1\XKwIHLsc5Qh[W6jbInzbZM> NEjoUFI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nk[xOFQxQCd-Mk[2NVQ1ODh:L3G+
HEL 92.1.7 NGTwfldHfW6ldHnvckBie3OjeR?= MVWyJIhzew>? MYnJcohq[mm2aX;uJI9nKEqDS{KgbY4hcHWvYX6gTGVNKDl{LkGuO{Bk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iU2TBWFUheGixc4Doc5J6dGG2aX;uJIFnfGW{IEKgbJJ{KGK7IGfld5Rmem5iYnzveEBidmGueYPpdy=> MkG5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ4MUS0NFgoRjJ4NkG0OFA5RC:jPh?=
DAOY MYfxTHRUKGG|c3H5 NULhc5lEeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFTBU3kh[2WubIO= NEDXTpg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SJ-GBM2 M2npepFJXFNiYYPzZZk> Mn\1dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFOMLVfCUVIh[2WubIO= NIS3Z4s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
A673 NFXWVVNyUFSVIHHzd4F6 Mn\qdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEF4N{OgZ4VtdHN? Mle5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-MC MVrxTHRUKGG|c3H5 MUTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= M1fpZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
BT-37 MkTWdWhVWyCjc4PhfS=> MVTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvM{egZ4VtdHN? M3vrNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
NB-EBc1 Mnq2dWhVWyCjc4PhfS=> NEDRc2FyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTlKtSWJkOSClZXzsdy=> M4DFTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Saos-2 NX\DT5dkeUiWUzDhd5NigQ>? M3;VVpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVYX;zMVIh[2WubIO= NVG2U|ExRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
SK-N-SH M4fQT5FJXFNiYYPzZZk> NXjyTW9PeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uW0hiY3XscJM> NF\qeGE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NB1643 MorRdWhVWyCjc4PhfS=> MV7xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVkJzNkSzJINmdGy| MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-12 MYrxTHRUKGG|c3H5 NFTrWGhyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStNVIh[2WubIO= NIDtTGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
OHS-50 NF;NZXlyUFSVIHHzd4F6 NHv2fpdyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiT1jTMVUxKGOnbHzz NVy2TJZJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
RD NXu1do11eUiWUzDhd5NigQ>? MlPtdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKGIHPlcIx{ NHvscpI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
MG 63 (6-TG R) MoLKdWhVWyCjc4PhfS=> MmP0dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE2JIE[zJEg3NVSJIGKpJINmdGy| M3;5fFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh41 NUe3R295eUiWUzDhd5NigQ>? NVyzeFVYeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLoOFEh[2WubIO= MoroQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-STAT3 / STAT3 / p-JAK2 / JAK2 ; 

PubMed: 22027691     


Cells were treated with AZD1480 for the indicated times, lysed and immunoblotted with the indicated antibodies. 

p-STAT1 / STAT1 / p-STAT5 / STAT5 / p-STAT6 / STAT6 ; 

PubMed: 22829094     


Western blot assay of the four HL cell lines treated with increasing doses of AZD1480 (0.1–5 μM) for 72 h. 

p-ERK / ERK / p-p38 / p38 / SOCS3 / p-SHP2 / SHP2 ; 

PubMed: 22829094     


Representative western blot assay showing increased levels of ERK, p38 and SHP-2 phosphorylation in HD-LM2 and L-428, after treatment for 72 h with increasing doses of AZD1480 (0.1-5 μM). In contrast, L-540 showed a dose-dependent inhibition of ERK and p38 activation without increased SHP-2 phosphorylation. SOCS-3 levels decreased in all the cell lines.

22027691 22829094
Immunofluorescence
pSTAT5; 

PubMed: 30140255     


HepG2 cells were incubated in the presence of Pro-Gly (0.5 mM) and/or AZD1480 (1 μM) for 6 h and phospho-STAT5 translocation to nuclei was detected by ICC. Scale bar, 10 μm. The IP and ICC experiments were conducted independently for 3 times, with 3 replicates each time.

30140255
Growth inhibition assay
Cell proliferation ; 

PubMed: 22027691     


Cells were treated with AZD1480 for the indicated times, and the WST-1 cell proliferation assay performed. The 48 and 72 h time points were statistically significant. Data represent mean ± SD, replicates of three (**, p<0.001; ANOVA). 

Cell viability; 

PubMed: 25855603     


IL-3-independent Ba/F3 cells were treated with increasing concentrations of the JAK inhibitor AZD1480 showing submicromolar inhibition of proliferation.

22027691 25855603
In vivo AZD1480 inhibits the STAT3 phosphorylation in an xenograft model of human solid tumors and multiple myeloma. [1] In vivo, AZD1480 inhibits the growth of subcutaneous tumors and increases survival of mice bearing intracranial glioblastoma (GBM) tumors by inhibiting STAT-3 activity, indicating that pharmacologic inhibition of the JAK/STAT-3 pathway by AZD1480 should be considered for study in the treatment of patients with GBM tumors. [3]AZD1480 blocks lung infiltration of myeloid cells and formation of pulmonary metastases in both mouse syngeneic experimental and spontaneous metastatic models. Furthermore, AZD1480 reduces angiogenesis and metastasis in a human xenograft tumor model. [4] The Jak2 inhibitor, AZD1480, suppresses the growth of human solid tumor xenografts harboring persistent Stat3 activity. [5]

Protocol

Kinase Assay:[5]
- Collapse

kinase assays:

Inhibition studies of AZD1480 are performed using recombinant Jak1, Jak2, or Jak3 under buffer conditions of 50 mM HEPES pH 7.3, 1 mM DTT, 0.01% Tween-20, 50 mM/ml BSA, and 10 mM MgCl2. Jak3 enzyme is expressed as N-terminal GST fusion in insect cells and purified by glutathione-affinity and size-exclusion chromatographies. Enzymes are assayed in the presence of AZD1480 (10 point dose response, in triplicate, from 8.3 μM to 0.3 nM in half-log dilution steps) using 1.5 μM peptide substrate (Jak1: FITC-C6-KKHTDDGYMPMSPGVA-NH2, Jak2 and Jak3: FAM-SRCtide) and screened under their respective ATP Km (Jak1: 55 μM, Jak2: 15 μM, Jak3: 3 μM) and approximated physiological ATP concentration of 5 mM. Phosphorylated and unphosphorylated peptides are separated and quantified by a Caliper LC3000 system for calculating percent inhibition.
Cell Research:[4]
- Collapse
  • Cell lines: Renca or 786-O cells, mouse endothelial cells and splenic CD11b+/c-myeloid cells, HUVECs
  • Concentrations: ~1 μM
  • Incubation Time: 48 or 24 hours
  • Method: Renca or 786-O cells are suspended in DMEM medium with 5% FBS , and seeded in 96-well plates (5×103 per well) to allow adhesion and then treated with DMSO or AZD1480 for 48 hours. Cell viability is determined by MTS assay. Absorbance at 490 nm is measured with Mikrotek Laborsysteme. Mouse endothelial cells and splenic CD11b+/c- myeloid cells are enriched from tumor-bearing mice,and cultured in 5% FBS RPMI-1640 medium. HUVECs are cultured on collagen 1–coated plates in complete medium. All cells are treated with DMSO and AZD1480 at various doses for 24 hours. Cell viability is determined by counting cell number manually. All the experiments are repeated 3 times.
    (Only for Reference)
Animal Research:[4]
- Collapse
  • Animal Models: Female BALB/c and athymic nude (NCR - nu/nu) mice (7–8 weeks old)
  • Dosages: Once a day at the dose of 50 mg/kg or twice daily at 30 mg/kg
  • Administration: Oral gavage
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 69 mg/mL warmed (197.83 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
30% PEG400+0.5% Tween80+5% propylene glycol
For best results, use promptly after mixing.
5 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 348.77
Formula

C14H14ClFN8

CAS No. 935666-88-9
Storage powder
in solvent
Synonyms N/A
Smiles CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01219543 Terminated Drug: AZD1480 Daily|Drug: AZD1480 BID Solid Tumour|Advanced Solid Malignancies|Child-Pugh A to B7 Advanced Hepatocellular Carcinoma|EGFR and/or ROS Mutant NSCLC|Lung Metastasis Carcinoma|Gastric Cancer AstraZeneca November 2010 Phase 1
NCT01112397 Terminated Drug: AZD1480 Solid Malignancies AstraZeneca April 2010 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

JAK Signaling Pathway Map

JAK Inhibitors with Unique Features

Related JAK Products

Tags: buy AZD1480|AZD1480 ic50|AZD1480 price|AZD1480 cost|AZD1480 solubility dmso|AZD1480 purchase|AZD1480 manufacturer|AZD1480 research buy|AZD1480 order|AZD1480 mouse|AZD1480 chemical structure|AZD1480 mw|AZD1480 molecular weight|AZD1480 datasheet|AZD1480 supplier|AZD1480 in vitro|AZD1480 cell line|AZD1480 concentration|AZD1480 nmr|AZD1480 in vivo|AZD1480 clinical trial|AZD1480 inhibitor|AZD1480 JAK/STAT inhibitor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID